88 related articles for article (PubMed ID: 15459315)
1. Remission of a refractory, anaplastic large-cell lymphoma after treatment with daclizumab.
Lindén O
N Engl J Med; 2004 Sep; 351(14):1466-7. PubMed ID: 15459315
[No Abstract] [Full Text] [Related]
2. Successful treatment with daclizumab of refractory anaplastic lymphoma.
Costa V; Oliva T; Norton L
Pediatr Blood Cancer; 2009 Dec; 53(6):1130-1. PubMed ID: 19598219
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
4. Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.
Go A; Venugopal P; Loew J; Djordjevic D
Clin Adv Hematol Oncol; 2006 Jun; 4(6):439-41. PubMed ID: 16981666
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of a combined rituximab chemotherapy during pregnancy.
Herold M; Schnohr S; Bittrich H
J Clin Oncol; 2001 Jul; 19(14):3439. PubMed ID: 11454895
[No Abstract] [Full Text] [Related]
6. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell lymphoma.
Habermann TM
Clin Adv Hematol Oncol; 2005 Nov; 3(11):suppl 4-5. PubMed ID: 16491628
[No Abstract] [Full Text] [Related]
9. Primary large B-cell lymphoma of the bone marrow.
Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
[No Abstract] [Full Text] [Related]
10. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
[TBL] [Abstract][Full Text] [Related]
11. HIV-related lymphoma treated with maintenance thalidomide.
Larson ML; Enschede SH; Gregory SA
Clin Adv Hematol Oncol; 2005 Mar; 3(3):231-4; discussion 234-5. PubMed ID: 16166993
[No Abstract] [Full Text] [Related]
12. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
[TBL] [Abstract][Full Text] [Related]
13. Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma.
Nagai H; Yano T; Watanabe T; Uike N; Okamura S; Hanada S; Kawano F; Sunami K; Inoue N; Sawamura M; Nishiura T; Hotta T; Horibe K
Br J Haematol; 2008 Dec; 143(5):672-80. PubMed ID: 18950459
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
Shimamoto T; Hayashi S; Ando K; Yguchi M; Miyazawa K; Kimura Y; Mukai K; Serizawa H; Ohyashiki K
Am J Hematol; 2001 Jan; 66(1):49-52. PubMed ID: 11426493
[TBL] [Abstract][Full Text] [Related]
15. Relapsed diffuse large B-cell lymphoma treated by reduced-intensity allogeneic stem cell transplantation with donor lymphocyte infusion.
Chaudhry QU; Ahmed P; Ullah K; Satti TM; Raza S; Mehmood SK; Akram M; Ahmed S
J Coll Physicians Surg Pak; 2010 Mar; 20(3):211-3. PubMed ID: 20392389
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies in the management of newly diagnosed, aggressive B-cell lymphoma.
Coiffier B
Curr Hematol Rep; 2003 Jan; 2(1):23-9. PubMed ID: 12901151
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of diffuse large B-cell lymphoma].
Gleissner B; Zwick C; Pfreundschuh M
Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
[TBL] [Abstract][Full Text] [Related]
18. Large B-cell non-Hodgkin's lymphoma presenting as a laryngeal cyst.
Agada FO; Mistry D; Grace AR; Coatesworth AP
J Laryngol Otol; 2005 Aug; 119(8):658-60. PubMed ID: 16102228
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
[No Abstract] [Full Text] [Related]
20. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
